finnCap - Allergy Therapeutics, Initiation of coverage
FCAP , AGY Mon, 09 Jan 2017, 08:45am GMT
finnCap initiate coverage on Allergy Therapeutics, a European specialty pharmaceutical business focused on immunotherapeutic vaccines for the treatment of moderate to severe allergies. It has a profitable underlying European business with growing market share and strong sales growth which finnCap value at 40p per share.
Jonathan Bright, Digital Content Marketing Manager
Thu, 23 Apr 2020, 10:00am BST
Sam Smith, CEO, finnCap
Thu, 27 Dec 2018, 10:00am GMT
Ambition Nation,
Thu, 1 Feb 2018, 10:00am GMT
Sam Smith, CEO, finnCap
Wed, 27 Dec 2017, 2:00pm GMT
Sam Smith, CEO, finnCap
Fri, 1 Dec 2017, 12:20pm GMT
Sam Smith, CEO, finnCap
Fri, 1 Dec 2017, 12:15pm GMT
Ambition Nation,
Fri, 1 Dec 2017, 12:10pm GMT
Ambition Nation,
Fri, 1 Dec 2017, 12:05pm GMT
Ambition Nation,
Fri, 1 Dec 2017, 12:00pm GMT
Stuart Andrews, Head of Corporate Finance
Tue, 24 Oct 2017, 2:32pm BST
Stuart Andrews, Head of Corporate Finance
Tue, 24 Oct 2017, 2:31pm BST
Funding Tech Disruptors
Tue, 24 Oct 2017, 2:30pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:20pm BST
Sam Smith, CEO, finnCap
Mon, 2 Oct 2017, 12:15pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:10pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:05pm BST
Female Entrepreneurs
Mon, 2 Oct 2017, 12:00pm BST
David Buxton, Analyst
Wed, 26 Jul 2017, 1:55pm BST